Goldman Sachs’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.4M | Sell |
1,110,366
-437,157
| -28% | -$4.17M | ﹤0.01% | 3123 |
|
|
2025
Q4 | $18.8M | Buy |
1,547,523
+751,555
| +94% | +$9.13M | ﹤0.01% | 2439 |
|
|
2025
Q3 | $9.3M | Buy |
795,968
+190,803
| +32% | +$2.28M | ﹤0.01% | 3033 |
|
|
2025
Q2 | $5.62M | Buy |
605,165
+23,156
| +4% | +$181K | ﹤0.01% | 3304 |
|
|
2025
Q1 | $4.27M | Sell |
582,009
-90,613
| -13% | -$696K | ﹤0.01% | 3513 |
|
|
2024
Q4 | $5.74M | Buy |
672,622
+96,384
| +17% | +$940K | ﹤0.01% | 3314 |
|
|
2024
Q3 | $5.01M | Sell |
576,238
-103,179
| -15% | -$850K | ﹤0.01% | 3341 |
|
|
2024
Q2 | $4.65M | Buy |
679,417
+410,236
| +152% | +$2.53M | ﹤0.01% | 3223 |
|
|
2024
Q1 | $2.45M | Buy |
269,181
+181,628
| +207% | +$1.29M | ﹤0.01% | 3715 |
|
|
2023
Q4 | $390K | Sell |
87,553
-27,833
| -24% | -$82.3K | ﹤0.01% | 4875 |
|
|
2023
Q3 | $362K | Sell |
115,386
-92,106
| -44% | -$377K | ﹤0.01% | 4806 |
|
|
2023
Q2 | $1.07M | Buy |
207,492
+26,827
| +15% | +$160K | ﹤0.01% | 4301 |
|
|
2023
Q1 | $952K | Sell |
180,665
-1,570
| -0.9% | -$7.46K | ﹤0.01% | 4409 |
|
|
2022
Q4 | $512K | Sell |
182,235
-150,512
| -45% | -$498K | ﹤0.01% | 4852 |
|
|
2022
Q3 | $1.38M | Sell |
332,747
-135,501
| -29% | -$683K | ﹤0.01% | 4293 |
|
|
2022
Q2 | $1.88M | Buy |
468,248
+83,858
| +22% | +$317K | ﹤0.01% | 4110 |
|
|
2022
Q1 | $1.9M | Buy |
384,390
+167,561
| +77% | +$929K | ﹤0.01% | 4310 |
|
|
2021
Q4 | $1.51M | Sell |
216,829
-101,937
| -32% | -$792K | ﹤0.01% | 4489 |
|
|
2021
Q3 | $3.19M | Sell |
318,766
-167,930
| -35% | -$1.89M | ﹤0.01% | 3764 |
|
|
2021
Q2 | $6.9M | Sell |
486,696
-151,053
| -24% | -$2.3M | ﹤0.01% | 3049 |
|
|
2021
Q1 | $10.5M | Buy |
637,749
+132,222
| +26% | +$2.55M | ﹤0.01% | 2529 |
|
|
2020
Q4 | $10.5M | Buy |
505,527
+380,576
| +305% | +$5.65M | ﹤0.01% | 2420 |
|
|
2020
Q3 | $951K | Sell |
124,951
-85,667
| -41% | -$711K | ﹤0.01% | 4114 |
|
|
2020
Q2 | $1.75M | Buy |
210,618
+125,482
| +147% | +$832K | ﹤0.01% | 3553 |
|
|
2020
Q1 | $421K | Buy |
85,136
+55,695
| +189% | +$275K | ﹤0.01% | 4310 |
|
|
2019
Q4 | $116K | Sell |
29,441
-18,845
| -39% | -$65.5K | ﹤0.01% | 5025 |
|
|
2019
Q3 | $147K | Buy |
48,286
+14,265
| +42% | +$63.8K | ﹤0.01% | 4908 |
|
|
2019
Q2 | $150K | Sell |
34,021
-22,042
| -39% | -$81.6K | ﹤0.01% | 4863 |
|
|
2019
Q1 | $223K | Sell |
56,063
-28,652
| -34% | -$115K | ﹤0.01% | 4752 |
|
|
2018
Q4 | $337K | Buy |
84,715
+36,308
| +75% | +$200K | ﹤0.01% | 4580 |
|
|
2018
Q3 | $333K | Sell |
48,407
-7,533
| -13% | -$47.3K | ﹤0.01% | 4659 |
|
|
2018
Q2 | $378K | Buy |
55,940
+12,816
| +30% | +$88.1K | ﹤0.01% | 4671 |
|
|
2018
Q1 | $281K | Buy |
43,124
+8,157
| +23% | +$45.9K | ﹤0.01% | 4816 |
|
|
2017
Q4 | $156K | Sell |
34,967
-1,792
| -5% | -$9.15K | ﹤0.01% | 5542 |
|
|
2017
Q3 | $227K | Buy |
36,759
+3,342
| +10% | +$21.5K | ﹤0.01% | 5677 |
|
|
2017
Q2 | $310K | Buy |
33,417
+1,422
| +4% | +$13.8K | ﹤0.01% | 5479 |
|
|
2017
Q1 | $297K | Sell |
31,995
-17,903
| -36% | -$149K | ﹤0.01% | 5471 |
|
|
2016
Q4 | $418K | Sell |
49,898
-22,285
| -31% | -$173K | ﹤0.01% | 5209 |
|
|
2016
Q3 | $496K | Buy |
72,183
+24,369
| +51% | +$149K | ﹤0.01% | 5048 |
|
|
2016
Q2 | $237K | Buy |
+47,814
| New | +$474K | ﹤0.01% | 5554 |
|
|
2015
Q3 | – | Sell |
-12,993
| Closed | -$273K | – | 7433 |
|
|
2015
Q2 | $273K | Buy |
+12,993
| New | +$322K | ﹤0.01% | 5837 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
